GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioGaia AB (OTCPK:BGLAF) » Definitions » PB Ratio

BioGaia AB (BioGaia AB) PB Ratio : 5.97 (As of May. 21, 2024)


View and export this data going back to 2013. Start your Free Trial

What is BioGaia AB PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-21), BioGaia AB's share price is $12.31. BioGaia AB's Book Value per Share for the quarter that ended in Mar. 2024 was $2.06. Hence, BioGaia AB's PB Ratio of today is 5.97.

The historical rank and industry rank for BioGaia AB's PB Ratio or its related term are showing as below:

BGLAF' s PB Ratio Range Over the Past 10 Years
Min: 4.21   Med: 11.74   Max: 20.63
Current: 6.1

During the past 13 years, BioGaia AB's highest PB Ratio was 20.63. The lowest was 4.21. And the median was 11.74.

BGLAF's PB Ratio is ranked worse than
88.27% of 955 companies
in the Drug Manufacturers industry
Industry Median: 2.02 vs BGLAF: 6.10

During the past 12 months, BioGaia AB's average Book Value Per Share Growth Rate was 3.90% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 5.20% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 32.60% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 21.80% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of BioGaia AB was 49.40% per year. The lowest was -17.50% per year. And the median was 14.40% per year.

Back to Basics: PB Ratio


BioGaia AB PB Ratio Historical Data

The historical data trend for BioGaia AB's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioGaia AB PB Ratio Chart

BioGaia AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.00 5.78 5.46 - 5.08

BioGaia AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.09 5.97 5.07 5.08 4.83

Competitive Comparison of BioGaia AB's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, BioGaia AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioGaia AB's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioGaia AB's PB Ratio distribution charts can be found below:

* The bar in red indicates where BioGaia AB's PB Ratio falls into.



BioGaia AB PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

BioGaia AB's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=12.31/2.062
=5.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


BioGaia AB  (OTCPK:BGLAF) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


BioGaia AB PB Ratio Related Terms

Thank you for viewing the detailed overview of BioGaia AB's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BioGaia AB (BioGaia AB) Business Description

Traded in Other Exchanges
Address
Kungsbroplan 3A, Stockholm, SWE, SE-112 27
BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions; Asia Pacific, Europe, the Middle East, Africa, and the Americas.